There has recently been an increase in data indicating that autoimmune mechanisms are involved in the etiopathogenesis of idiopathic thrombocytopenic purpura (ITP) (1, 2). Although antibodies that react with platelets are found in most patients with ITP, the pathogenetic nature of the antibodies remains to be clarified . The discovery of an animal model for ITP has therefore been long-awaited. Here we have found that (NZW x BXSB)Fi (W/B Fi) mice, which develop lupus nephritis with myocardial infarction (3), show thrombocytopenia with age, and that this is due to the presence ofboth platelet-associated antibodies (PAA) and circulating antiplatelet antibodies.
washing twice, the platelets were resuspended in EDTA-PBS to a platelet count of 2 x 10`'/100 pl. To detect the circulating antibodies, aliquots of platelets were incubated with 100 Al of plasma (1 :4 dilution) for 30 min at room temperature . As a postive control, the platelets of BALB/c mice were treated with anti-H-2' sera. After washing twice, they were then incubated with a 1 :10 dilution ofFITC-conjugated antisera (goat anti-mouse Ig; Cappel Laboratories, West Chester, PA; goat anti-mouse IgG, IgA, IgM ; Behring Institute, Marburg, Federal Republic of Germany) for 30 min at room temperature . After final washing, samples were then analyzed on a FAGS analyzer (Becton Dickinson & Co., Sunnyvale, CA) by gating to exclude debrils . The nonstained negative control (autofluorescence) was set at channels 0 to 8. The percentage of positive cells was calculated from the total platelet count above channel 9 .
Transplantation of Bone Marrow Cells. 3-5-mo-old W/B F, males were exposed to 9.5 Gy from a 'Co source and then reconstituted by intravenous injection of 1 .4 x 10' bone marrow cells from BALB/c nu/nu mice, as previously described (4) . The mice were killed 5.5 mo after ABMT.
Platelet and Megakaryocyte Count.
Platelet counts in the peripheral blood were made in heparin blood sample on a hemocytometer. For megakaryocyte count, femur and tibia were obtained at sacrifice, and sections stained with hematoxylin and eosin. The number of megakaryocytes per square millimeter was counted under a microscope.
Results
Male W/B Ft mice at the age of 1-2 .5 mo showed platelet counts similar to those of BALB/c, NZW, and BXSB mice (Table I) . W/B Ft mice at the age of >4.5 mo, however, showed a marked reduction in platelet count. In contrast, bone marrow megakaryocyte counts increased in these mice with age, though they retained their normal shape.
To elucidate the cause of thrombocytopenia in peripheral blood of W/B Ft mice, we first examined PAA on the platelets . As shown in Fig . 1 , PAA were found in the platelets of 4.5-mo-old W/B Ft mice with thrombocytopenia (10 .5 x 104/pí). BALB/c platelets treated with anti-H-2' serum were used as a positive control .
The next step was to examine whether circulating antiplatelet antibodies are present in the plasma of aged W/B F, mice. As shown in Table II , circulating antiplatelet antibodies were found in the plasma of W/B Ft mice that were >5 mo old .
The characterization of the antiplatelet antibodies revealed that both PAA and circulating antiplatelet antibodies belong to the IgG and IgM classes, but not IgA (Table III) .
Since we know that ABMT has curative effects on autoimmune diseases (4-6), W/B Fi mice at the age of3-5 mo were lethally (9.5 Gy) irradiated and then recon- Platelet-associated antibodies in W/B Fi mice . Aliquots of the platelets (2 x 10 6) were labeled with FITC-antimouse Ig and analyzed on a FAGS analyzer. As a positive control, BALB/c platelets treated with anti-H-2 a antisera were used . Platelet counts (Plt . count : x 10 -s /ml) for each mouse are shown . stituted with bone marrow cells from BALB/c nu/nu mice. The mice were killed 5 .5 mo after ABMT W/B F1 mice reconstituted with BALB/c nu/nu bone marrow cells showed normal platelet counts even at the age of 10.5 mo, and the levels ofantiplatelet antibodies were reduced to those of BALB/c mice (Table IV) .
Discussion
In the present study we have demonstrated that W/B F1 mice develop thrombocytopenia with age, and have found the presence of both PAA and circulating antiplatelet antibodies in such mice.
Several mechanisms that would explain the cause of thrombocytopenia in patients with ITP have been proposed . One is the presence of antiplatelet antibodies, which results in platelet destruction by complement-mediated lysis (8) or sequestration by the reticuloendothelial system (1) . It has been reported that the antibodies in humans belong mainly to the IgG class (9) . In W/B F1 mice, we have found the presence of IgG and IgM (but not IgA) antibodies both in the plasma and on the platelets (Table III) (CICs) from the age of 2.5 mo (3), it is conceivable that CICs are involved in the development of thrombocytopenia, CICs being found to affect platelets by activating complement or platelet-aggregating factor (1, 2) . However, murine platelets have no Fc receptors (2) , and the sera from BXSB (Table III) and MRL/lpr (data not shown) mice, which show high CIC levels, did not bind to the platelets of BALB/c mice. It is therefore unlikely that antibodies bound to platelets and circulating antiplatelet antibodies exist as a form of CIC. Hang et al. (10) investigated the etiopathogenesis ofautoimmune diseases in these W/B F1 mice by reciprocal transfer experiments of spleen cells between males that exhibit early-onset autoimmune disease and females with late-onset autoimmune diseases ; the transfer of male lymphoid cells to female mice caused the development of accelerated lupus nephritis, hypertension, and myocardial infarction, whereas the transfer of female lymphoid cells to male mice delayed the onset . We have recently demonstrated that the transplantation of bone marrow cells from normal mice to autoimmune-prone mice has curative effects on autoimmune diseases, such as lupus nephritis, lupoid hepatitis, rheumatoid arthritis, and type I diabetes mellitus (4) (5) (6) . In the present study, W/B F1 mice after ABMT showed normal platelet counts and no evidence of the presence of circulating antiplatelet antibodies even at the age of 10.5 mo (Table IV) . These results provide additional evidence that autoimmune mechanisms are involved in the development of thrombocytopenia in W/B F1 mice, although the exact mechanism by which it develops remains to be clarified .
We thus think that W/B 1 mice serve as a useful animal model of ITP not only for elucidating the mechanism of the development of antiplatelet antibodies, but also for characterizing autoantibodies to platelets . mice at the age of >5 mo, whereas megakaryocyte counts were found to increase in such mice. FACS analyses revealed the presence of both platelet-associated antibodies (PAA) and circulating antiplatelet antibodies . There is a correlation between the presence of these antibodies and the degree of thrombocytopenia. The transplantation of normal bone marrow cells from BALB/c nu/nu mice to W/B Fi mice was found to have preventative and curative effects on thrombocytopenia ; the mice showed normal platelet counts and no evidence of circulating antiplatelet antibodies .
These results indicate that thrombocytopenia in W/B Fi mice is due to the presence of antibodies to platelets . We therefore think that W/B F, mice serve as a useful animal model of idiopathic thrombocytopenic purpura (ITP) not only for elucidating the mechanism of the development of antiplatelet antibodies, but also for characterizing autoantibodies to platelets .
